Vor Bio grants inducement equity awards to 9 new hires under Nasdaq rule

Reuters04-02
Vor Bio grants inducement equity awards to 9 new hires under Nasdaq rule
  • Vor Bio granted inducement equity awards to 9 new hires on April 1, 2026.
  • Awards covered options for 42,650 shares plus RSUs for 9,050 shares.
  • Option exercise price set at $17.39 per share.
  • Options vest over four years, with 25% vesting at 12 months.
  • RSUs vest over four years, with 25% vesting at 12 months.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vor Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604011700PRIMZONEFULLFEED9682996) on April 01, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment